… with rheumatic diseases were reported and SARS–CoV-2 … data regarding patients with
rheumatic diseases, did not … data regarding outcomes related to SARS–CoV-2 infection or its …

… The SARS-CoV-2 infection also shares similar molecular networks with RDs … rheumatic
diseases, such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and rheumatic …

… outcomes of rheumatic and musculoskeletal disease (RMD) … acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) … Rheumatology Department of our hospital were screened for …

… Whether patients with autoimmune rheumatic diseases (ARD) have a higher risk for
SARS-CoV-2 infection (COVID-19) and how SARS-CoV-2 pandemic impacts on adherence to …

… positive for SARS-CoV-2, we excluded 300 known to have prevalent rheumatic disease
that … cases of incident systemic rheumatic disease after negative PCR results for SARS-CoV-2. …

… coronavirus 2 (SARS-CoV-2) and the disease caused by SARS-CoV-2, coronavirus disease
… of the pandemic for patients with rheumatic and musculoskeletal diseases (RMDs), at a time …

Globally, the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), appeared to have a milder clinical course in children …

… are affected by rheumatic diseases and over 5 and a half million men and women affected
by rheumatological diseases are present in Italy. These are chronic diseases and therefore …

… criteria: (a) onset of the rheumatic manifestations within 4 weeks from SARS-CoV-2 infection
or (b) onset of the rheumatic manifestations within 4 weeks from the administration of one of …

… The registration trials of messenger RNA (mRNA) vaccines against SARS-CoV-2 did not
address patients with inflammatory rheumatic diseases (IRD).1 2 Concerns were raised …